Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Maria E. Lozada; Roongruedee Chaiteerakij; Lewis R. Roberts

doi:10.1007/s11901-015-0261-y

Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Maria E. Lozada, Roongruedee Chaiteerakij, Lewis R. Roberts

Gastroenterology and Hepatology

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Treatment of liver and biliary tract cancer is most effective for early and localized disease. Effective screening methods for hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) will lead to early detection and treatment, and thus improvement in survival. Patients at risk of developing HCC and CCA will benefit the most from effective surveillance strategies. In this review, we provide an update on the current status of HCC and CCA surveillance and describe the recent efforts on biomarker development.

Original language	English (US)
Article number	A004
Pages (from-to)	128-138
Number of pages	11
Journal	Current Hepatitis Reports
Volume	14
Issue number	2
DOIs	https://doi.org/10.1007/s11901-015-0261-y
State	Published - Jun 2015

Keywords

Bile duct cancer
Diagnosis
Early detection
Liver cancer
Surveillance

ASJC Scopus subject areas

Hepatology
Virology

Access to Document

10.1007/s11901-015-0261-y

Cite this

@article{3e54b3f11fb0499ca640f937d60a91b9,

title = "Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?",

abstract = "Treatment of liver and biliary tract cancer is most effective for early and localized disease. Effective screening methods for hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) will lead to early detection and treatment, and thus improvement in survival. Patients at risk of developing HCC and CCA will benefit the most from effective surveillance strategies. In this review, we provide an update on the current status of HCC and CCA surveillance and describe the recent efforts on biomarker development.",

keywords = "Bile duct cancer, Diagnosis, Early detection, Liver cancer, Surveillance",

author = "Lozada, {Maria E.} and Roongruedee Chaiteerakij and Roberts, {Lewis R.}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2015.",

year = "2015",

month = jun,

doi = "10.1007/s11901-015-0261-y",

language = "English (US)",

volume = "14",

pages = "128--138",

journal = "Current Hepatitis Reports",

issn = "1540-3416",

publisher = "Springer Publishing Company",

number = "2",

}

TY - JOUR

T1 - Screening for hepatocellular carcinoma and cholangiocarcinoma

T2 - Can biomarkers replace imaging?

AU - Lozada, Maria E.

AU - Chaiteerakij, Roongruedee

AU - Roberts, Lewis R.

N1 - Publisher Copyright: © Springer Science+Business Media New York 2015.

PY - 2015/6

Y1 - 2015/6

N2 - Treatment of liver and biliary tract cancer is most effective for early and localized disease. Effective screening methods for hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) will lead to early detection and treatment, and thus improvement in survival. Patients at risk of developing HCC and CCA will benefit the most from effective surveillance strategies. In this review, we provide an update on the current status of HCC and CCA surveillance and describe the recent efforts on biomarker development.

AB - Treatment of liver and biliary tract cancer is most effective for early and localized disease. Effective screening methods for hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) will lead to early detection and treatment, and thus improvement in survival. Patients at risk of developing HCC and CCA will benefit the most from effective surveillance strategies. In this review, we provide an update on the current status of HCC and CCA surveillance and describe the recent efforts on biomarker development.

KW - Bile duct cancer

KW - Diagnosis

KW - Early detection

KW - Liver cancer

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=84943234689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943234689&partnerID=8YFLogxK

U2 - 10.1007/s11901-015-0261-y

DO - 10.1007/s11901-015-0261-y

M3 - Article

AN - SCOPUS:84943234689

SN - 1540-3416

VL - 14

SP - 128

EP - 138

JO - Current Hepatitis Reports

JF - Current Hepatitis Reports

IS - 2

M1 - A004

ER -

Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this